Abstract
Chronic kidney disease in both predialysis patients and renal replacement therapy patients is connected with an increased risk of death, mainly due to cardiovascular diseases (56%), infections (11.2%) and neoplastic diseases (8%). The longer the dialysis duration, the greater incidence of malignancy. The prevalance of renal cell carcinoma (RCC) in patients with end stage renal disease on dialysis is reported to be higher than in the general population. The frequency of acquired cystic kidney disease (ACKD) increases with the duration of dialysis. ACKD-associated RCC tumors tend to be more common in males and often bilateral and multicentric. Oncocytoma from renal cell tumors is regarded as a variant tumor and may be histopathologically malignant although it is accepted as a benign tumor. This article will describe a renal mass that has been routinely detected in a patient who has been on dialysis treatment for a long time and who has no complaints.
References
- 1- Cengiz K. Increased incidance of neoplasia in chronic renal failure (20-year experience). International Urology and Nephrology 2002; 33(1): 121-26. 2- Herr H, Kim JU, Kang GH, Moon KC, Koh JK. Kaposi’s sarcoma occuring during shot-term dialysis: report of two cases. J Korean Med Sci 2001; 16: 130-4. 3- Pecqueux JC, Schwarz A, Dieckmann KP, Offermann G. Cancer incidance in patients on chronic dialysis and in renal transplant recipients. Urol Int 1990; 45: 290-2.4- De Sala OE, Morey MA, Ferrutxe FJ, Guttierrez Sanz-Gadea C, Alarcon Zurita A et al. Cancer of the bladder and hemodialysis. Arch Esp Urol 1990; 43: 359-63.5- Fairley CK, Sheil AG, McNeil JJ, Ugoni AM, Disney AP, Giles GG et al. The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol 1994; 41: 101-5.6- Kabaria R, Klaassen Z, Terris MK. Renal cell carcinoma: links and risks. International Journal of Nephrology and Renovascular Disease 2016; 9: 45-52.7- Lee HH, Choi KH, Yang SC, Han WK. Renal cell carcinoma in kidney transplant recipients and dialysis patients. Korean J Urol 2012; 53(4): 229-33.8- Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7(5): 245-57.9- Heinz-Peer G, Schoder M, Rand T, Mayer G, Mostbeck GH. Prevalance of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study. Radiology 1995; 195: 66710- Truong LD, Krishnan B, Cao JT, Barrios R, Suki WN. Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis 1995; 26: 1-12.11- Kade G, Lubas A, Bodnar L, Szczylik C, Wankowicz Z. Malignant tumors in patients with end stage renal failure undergoing renal replacement theraphy. Wspolczesna Onkol. 2012; 16 (5): 382-87. 12- Şen S, Sarsık B. Sınıflandırılamayan böbrek tümörü ne demektir ve önemi nedir. Üroonkoloji Bülteni 2010; 3: 63-67.13- Mete Ö, Kılıçaslan I, Uysal V. Onkositom ile eozinofilik hücreli kromofob tipte böbrek hücreli karsinom ayırımında histomorfolojik özelliklerin önemi. Türk Patoloji Dergisi 2005; 21 (3-4): 62-66.14- Przybycin CG, Harper HL, Reynolds JP, Magi-Galluzzi C, Nguyen JK, Wu A et all. Acquired Cyctic Disease-associated renal cell carcinoma (ACD-RCC). A multiinstitutional study of 40 cases with clinical follow-up 2018; May 30; 1-415- Holley J L. Screening, Diagnosis, and Treatment of Cancer in Long-term Dialysis patients. Clinical Journal of The American Society of Nephrology 2007; 2(3): 604-610.
Abstract
Kronik böbrek yetmezlikli ve renal replasman tedavisi gören hastalarda kardiyovasküler hastalıklar (%56), infeksiyonlar (%11.2) ve maligniteye (%8) bağlı artmış mortalite oranları söz konusudur. Diyaliz süresi uzadıkça malignite görülme oranı da artar. Diyaliz hastalarında renal hücreli karsinom (RCC) prevalansının genel popülasyona göre daha yüksek olduğu bilinmektedir. Edinilmiş kistik böbrek hastalığı (ACKD) sıklığı diyaliz süresi ile artar; CKD ile ilişkili RCC erkeklerde daha sık görülür; sıklıkla bilateral ve multisentriktir. Renal hücreli tümörlerden olan onkositom varyant bir tümör olarak kabul edilmesine rağmen histopatolojik olarak malign tümör özellikleri gösterebilir. Bu yazıda uzun süreden beri hemodiyaliz tedavisi gören ve yakınması olmayan hastada rastlantısal olarak saptanan renal kitleler anlatılmaktadır.
References
- 1- Cengiz K. Increased incidance of neoplasia in chronic renal failure (20-year experience). International Urology and Nephrology 2002; 33(1): 121-26. 2- Herr H, Kim JU, Kang GH, Moon KC, Koh JK. Kaposi’s sarcoma occuring during shot-term dialysis: report of two cases. J Korean Med Sci 2001; 16: 130-4. 3- Pecqueux JC, Schwarz A, Dieckmann KP, Offermann G. Cancer incidance in patients on chronic dialysis and in renal transplant recipients. Urol Int 1990; 45: 290-2.4- De Sala OE, Morey MA, Ferrutxe FJ, Guttierrez Sanz-Gadea C, Alarcon Zurita A et al. Cancer of the bladder and hemodialysis. Arch Esp Urol 1990; 43: 359-63.5- Fairley CK, Sheil AG, McNeil JJ, Ugoni AM, Disney AP, Giles GG et al. The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol 1994; 41: 101-5.6- Kabaria R, Klaassen Z, Terris MK. Renal cell carcinoma: links and risks. International Journal of Nephrology and Renovascular Disease 2016; 9: 45-52.7- Lee HH, Choi KH, Yang SC, Han WK. Renal cell carcinoma in kidney transplant recipients and dialysis patients. Korean J Urol 2012; 53(4): 229-33.8- Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7(5): 245-57.9- Heinz-Peer G, Schoder M, Rand T, Mayer G, Mostbeck GH. Prevalance of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study. Radiology 1995; 195: 66710- Truong LD, Krishnan B, Cao JT, Barrios R, Suki WN. Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis 1995; 26: 1-12.11- Kade G, Lubas A, Bodnar L, Szczylik C, Wankowicz Z. Malignant tumors in patients with end stage renal failure undergoing renal replacement theraphy. Wspolczesna Onkol. 2012; 16 (5): 382-87. 12- Şen S, Sarsık B. Sınıflandırılamayan böbrek tümörü ne demektir ve önemi nedir. Üroonkoloji Bülteni 2010; 3: 63-67.13- Mete Ö, Kılıçaslan I, Uysal V. Onkositom ile eozinofilik hücreli kromofob tipte böbrek hücreli karsinom ayırımında histomorfolojik özelliklerin önemi. Türk Patoloji Dergisi 2005; 21 (3-4): 62-66.14- Przybycin CG, Harper HL, Reynolds JP, Magi-Galluzzi C, Nguyen JK, Wu A et all. Acquired Cyctic Disease-associated renal cell carcinoma (ACD-RCC). A multiinstitutional study of 40 cases with clinical follow-up 2018; May 30; 1-415- Holley J L. Screening, Diagnosis, and Treatment of Cancer in Long-term Dialysis patients. Clinical Journal of The American Society of Nephrology 2007; 2(3): 604-610.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Clinical Sciences |
| Journal Section | Case Report |
| Authors | |
| Publication Date | March 20, 2020 |
| Acceptance Date | November 6, 2018 |
| Published in Issue | Year 2020 Volume: 21 Issue: 1 |
Cite
